RYZB Annual EBITDA
-$72.00 M
-$1.41 M-2.00%
01 September 2023
Summary:
As of February 5, 2025, RYZB annual earnings before interest, taxes, depreciation & amortization is -$72.00 million, with the most recent change of -$1.41 million (-2.00%) on September 1, 2023. During the last 3 years, it has fallen by -$65.29 million (-973.35%).RYZB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYZB Quarterly EBITDA
-$21.15 M
0.00%
30 September 2023
Summary:
As of February 5, 2025, RYZB quarterly earnings before interest, taxes, depreciation & amortization is -$21.15 millionOver the past year, it has dropped by -$605.00 thousand (-2.94%).RYZB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYZB TTM EBITDA
-$38.19 M
0.00%
30 September 2023
Summary:
As of February 5, 2025, RYZB TTM earnings before interest, taxes, depreciation & amortization is -$38.19 millionOver the past year, it has dropped by -$17.65 million (-85.89%).RYZB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYZB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.0% | -2.9% | -85.9% |
| 3 y3 years | -973.4% | -2.9% | -85.9% |
| 5 y5 years | -973.4% | -2.9% | -85.9% |
RYZB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +973.3% | +24.1% | +85.9% |
RayzeBio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$21.15 M(+24.1%) | -$38.19 M(+1.6%) |
| Sept 2023 | -$72.00 M(+2.0%) | - | - |
| Dec 2022 | -$70.59 M | -$17.04 M(-17.1%) | -$37.59 M(+82.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$20.55 M | -$20.55 M |
| Dec 2021 | -$38.92 M(+480.3%) | - | - |
| Dec 2020 | -$6.71 M | - | - |
FAQ
- What is RayzeBio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for RayzeBio?
- What is RayzeBio annual EBITDA year-on-year change?
- What is RayzeBio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for RayzeBio?
- What is RayzeBio quarterly EBITDA year-on-year change?
- What is RayzeBio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for RayzeBio?
- What is RayzeBio TTM EBITDA year-on-year change?
What is RayzeBio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RYZB is -$72.00 M
What is the all time high annual EBITDA for RayzeBio?
RayzeBio all-time high annual earnings before interest, taxes, depreciation & amortization is -$6.71 M
What is RayzeBio annual EBITDA year-on-year change?
Over the past year, RYZB annual earnings before interest, taxes, depreciation & amortization has changed by -$1.41 M (-2.00%)
What is RayzeBio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RYZB is -$21.15 M
What is the all time high quarterly EBITDA for RayzeBio?
RayzeBio all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$17.04 M
What is RayzeBio quarterly EBITDA year-on-year change?
Over the past year, RYZB quarterly earnings before interest, taxes, depreciation & amortization has changed by -$605.00 K (-2.94%)
What is RayzeBio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RYZB is -$38.19 M
What is the all time high TTM EBITDA for RayzeBio?
RayzeBio all-time high TTM earnings before interest, taxes, depreciation & amortization is -$20.55 M
What is RayzeBio TTM EBITDA year-on-year change?
Over the past year, RYZB TTM earnings before interest, taxes, depreciation & amortization has changed by -$17.65 M (-85.89%)